Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Intezyne Partners with Exosome Diagnostics on IT-139 Companion Diagnostic
Monday, March 19, 2018Intezyne a clinicalstage biopharmaceutical company developing novel anticancer therapies announced that it has partnered with Exosome Diagnostics a privately held company focused on developing and commercializing revolutionary biofluidbased diagnosti...
Lundbeck to acquire Prexton Therapeutics
Saturday, March 17, 2018H Lundbeck AS Lundbeck and Prexton Therapeutics BV Prexton today announced signing of a definitive agreement in which Lundbeck will acquire Prexton Under terms of the agreement Lundbeck will pay EUR million approximately DKK million upfront and is...
Janssen Announces U.S. FDA Breakthrough Therapy Designation for Erdafitinib in the Treatment of Metastatic Urothelial Cancer
Friday, March 16, 2018The Janssen Pharmaceutical Companies of Johnson Johnson announced today that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation for erdafitinib in the treatment of urothelial cancer Urothelial cancer most frequently...
Ionis and Akcea Partner to Commercialize Inotersen for hATTR
Friday, March 16, 2018Ionis Pharmaceuticals and Akcea Therapeutics Inc an affiliate of Ionis today announced an exclusive worldwide license by Ionis to Akcea for inotersen and AKCEATTRLRx formerly IONISTTRLRx in a transaction potentially worth up to approximately billion...
OxThera Announces the Randomization of the First Patient Into its Phase III EPHEX Study With Oxabact
Thursday, March 15, 2018OxThera AB a Stockholmbased privatelyheld biopharmaceutical company with a product in late stage clinical development focusing on Primary hyperoxaluria PH announces the randomization of the first patient into its phase III study EPHEX with Oxabact...
Propanc Biopharma Completes Successful Reproduction Run for PRP
Thursday, March 15, 2018Propanc Biopharma Inc a clinical stage biopharmaceutical company focusing on development of new and proprietary treatments for cancer patients suffering from solid tumors such as pancreatic ovarian and colorectal cancers today announced the successfu...
Precision Therapeutics Subsidiary, TumorGenesis, Announces License Agreement with SyntArray, LLC
Wednesday, March 14, 2018Precision Therapeutics Inc formerly Skyline Medical announced that its wholly owned subsidiary TumorGenesis Inc has secured a license agreement with SyntArray LLC This license agreement will advance the Companys strategic plan to develop the next gen...
PAREXEL and CHA Medical Group Partner to Enhance Early Phase Clinical Research in Korea
Wednesday, March 14, 2018PAREXEL International Corporation the worlds leading innovator of biopharmaceutical services today announced an alliance with CHA Medical Group CHA to enhance early phase clinical development in Korea The collaboration is designed to provide biopharm...
MYR Pharma Completes Clinical Trial of Myrcludex B in Chronic Hepatitis Delta
Tuesday, March 13, 2018MYR Pharma GmbH today announced the completion of its MYR clinical trial a Phase b study investigating Myrcludex B in chronic hepatitis Delta HDV the most severe form of viral hepatitis that currently has no satisfactory treatment options A total of...
Biogen to buy Pfizer's neurology drug in deal nearing $600 million
Tuesday, March 13, 2018Biogen Inc said on Monday it would buy Pfizer Incs experimental treatment for a symptom associated with schizophrenia in a deal that could near million and mark its foray into the emerging market for neuropsychiatry Biogen said it plans to start...
